Article
Population pharmacokinetics analysis of cyclophosphamide with genetic effects in patients undergoing hematopoietic stem cell transplantation.
European journal of clinical pharmacology - 1 Aug 2013
Kim In-Wha, Yun Hwi-yeol, Choi Boyoon, Han Nayoung, Kim Myeong Gyu, Park Seonyang, Oh Jung Mi
Abstract excerpt
PURPOSE: To build a population pharmacokinetic (PK) model of cyclophosphamide (CY) and its metabolite, 4-hydroxycyclophosphamide (HCY), in patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT) and to identify covariates, including genetic polymorphisms, which affect CY and HCY PK parameters. METHOD: The study cohort comprised 21 patients undergoing HSCT who received CY intravenously...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
